Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio (2020 - 2024)

Historic FCF Payout Ratio for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q4 2024 value amounting to 0.0.

  • Maravai Lifesciences Holdings' FCF Payout Ratio changed N/A to 0.0 in Q4 2024 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year increase of 8604.81%. This contributed to the annual value of 0.02 for FY2024, which is 11405.74% down from last year.
  • As of Q4 2024, Maravai Lifesciences Holdings' FCF Payout Ratio stood at 0.0.
  • Maravai Lifesciences Holdings' FCF Payout Ratio's 5-year high stood at 1.7 during Q4 2020, with a 5-year trough of 0.22 in Q2 2023.
  • Its 5-year average for FCF Payout Ratio is 0.34, with a median of 0.25 in 2022.
  • In the last 5 years, Maravai Lifesciences Holdings' FCF Payout Ratio surged by 1618426.9% in 2021 and then plummeted by 18496.18% in 2023.
  • Maravai Lifesciences Holdings' FCF Payout Ratio (Quarter) stood at 1.7 in 2020, then crashed by 47.62% to 0.89 in 2021, then crashed by 62.62% to 0.33 in 2022, then plummeted by 167.02% to 0.22 in 2023, then surged by 101.71% to 0.0 in 2024.
  • Its FCF Payout Ratio was 0.0 in Q4 2024, compared to 0.07 in Q2 2024 and 0.22 in Q2 2023.